MDalert.com is designed to help physicians in all specialties succeed in this new world of performance-driven healthcare.
January 21, 2022

Axicabtagene Ciloleucel Highly Effective as Second-Line Treatment for Patients With Relapsed, Refractory LBCL

By Cameron Kelsall, MD /alert Contributor
Second-line treatment with axicabtagene ciloleucel significantly improved event-free survival (EFS) and response rates in patients with relapsed or refractory large B-cell lymphoma (LBCL) in comparison to standard treatments...
Axicabtagene Ciloleucel Highly Effective as Second-Line Treatment for Patients With Relapsed, Refractory LBCL
January 20, 2022

Smoking Linked to Higher Disease Severity for Primary Progressive Multiple Sclerosis

By Adam Hochron, Staff Writer
Patients who smoked after the onset of primary progressive multiple sclerosis had higher age-related MS severity scores (ARMSS)...
Smoking Linked to Higher Disease Severity for Primary Progressive Multiple Sclerosis
January 19, 2022

FDA Approves Tralokinumab for Atopic Dermatitis in Adults

By Andrew John, MD /alert Contributor
The FDA has approved tralokinumab for treating moderate to severe atopic dermatitis in adults...
FDA Approves Tralokinumab for Atopic Dermatitis in Adults
January 17, 2022

Immune Blood Cell Count Can Predict Survival for Lung Cancer Patients on Atezolizumab

By Mara Shapiro, Staff Writer
Early blood cell count testing can predict survival in patients with non-small cell lung cancer being treated with atezolizumab...
Immune Blood Cell Count Can Predict Survival for Lung Cancer Patients on Atezolizumab
January 14, 2022

CDC: Hepatitis C Treatment Declined in the US Between 2015 and 2020

By Jeff Craven, MD /alert Contributor
Fewer people living with hepatitis C (HCV) initiated treatment with direct-acting antivirals (DAA) in the United States between 2015 and 2020...
CDC: Hepatitis C Treatment Declined in the US Between 2015 and 2020
View More
Loading...

Trending News

In cooperation with Reuters News and Reuters Health, we are proud to provide you with our continuously updated news feed. We select news that applies to physicians in all the major clinical specialties, as well as on finance, science, technology, and other areas.

Reuters Health Medical News

CORRECTED-Stem cell-derived pancreatic cells may be alternative to islet transplants

(In second sentence of paragraph 7, changes first word from "Three" to "Six": Six (35.3%) showed positive...) By Marilynn Larkin NEW YORK (Reuters Health) - An ongoing first-in-human trial suggests Read More »

Radiomic signature may predict survival in pembrolizumab-treated advanced melanoma

By Marilynn Larkin NEW YORK (Reuters Health) - In patients with advanced melanoma treated with pembrolizumab monotherapy, a radiomic signature derived from baseline computed tomography (CT) images may Read More »

Drugmaker Teva fueled opioid addiction in New York, jury finds

By Brendan Pierson NEW YORK (Reuters) - Teva Pharmaceutical Industries Ltd fueled opioid addiction in New York state, a jury found on Thursday, a setback for a company still facing thousands of other Read More »

COVID is less severe with Omicron than Delta, U.S. study suggests

By Manojna Maddipatla and Leroy Leo (Reuters) - The Omicron variant appears to result in less severe COVID-19 than seen during previous periods of high coronavirus transmission including the Delta Read More »

No benefit to adding radiation to PD-L1/CTLA-4 therapy in resistant metastatic NSCLC

By Marilynn Larkin NEW YORK (Reuters Health) - In patients with resistant metastatic non-small-cell lung cancer (NSCLC), adding radiation to PD-L1 and CTLA-4 inhibition alone or combination did not Read More »

Menstrual blood sequencing effective for HPV screening

By Reuters Staff (Reuters Health) - Screening for human papillomavirus (HPV) in high-risk individuals may be done effectively and noninvasively using menstrual blood testing with target-capture Read More »

EXCLUSIVE-U.S. funding to WHO fell by 25% during pandemic -document

By Francesco Guarascio and Emma Farge BRUSSELS/GENEVA (Reuters) - U.S. financial contributions to the World Health Organization (WHO) has fallen by 25% during the coronavirus pandemic, provisional Read More »

Fauci says 'prudent' to have Omicron vaccine, but may not be needed

By Reuters Staff WASHINGTON (Reuters) - A COVID-19 vaccine specifically targeting the Omicron variant would be "prudent" even if it ultimately may not be needed, the top U.S. infectious disease Read More »

See all news »

Clinical Trials

Use our ClinicalTrials.gov feed to find trials in which your patients could enroll. In some cases, experimental drugs are a patient’s only hope. This section will regularly report on trials in the most common disease states, as they are getting underway.